BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...

Tumour necrosis factor alpha (TNF-α) inhibitors are licensed for use in autoimmune conditions such as psoriasis, and there have been reported cases of liver injury associated with infliximab and ...

Please provide your email address to receive an email when new articles are posted on . Anti-TNF use was significantly associated with higher risk for progressive kidney function decline among ...

NEW YORK (Reuters Health) - Patients with rheumatoid arthritis who fail to respond to one of the biological drugs will often have a better response to a second drug within the same class, Danish ...